Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa Bay news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Charlotte news in your inbox

Catch up on the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Paul Sancya / AP

In the first known U.S. study, scientists have successfully corrected a genetic mutation — one which causes the heart muscle to be unusually thick — in human embryos. The MIT Technology Review first learned of the results last week and called them "a milestone." Down the line, the research could advance to clinical trials in which researchers work with parents to correct mutations in embryos, but that raises the ethical question: If something goes wrong, what do you do?

Why it matters: This was "a cleaner study" and a more successful use of the gene-editing technique CRISPR than we've seen before, bioethicist Jessica Berg told Axios. The researchers, based in Oregon, corrected the genetic mutation in one cell and passed that correction to more embryonic cells, as they began to divide. Past studies carried out in China found errors in some cells after division.

  • One existing option for parents is pre-implantation genetic diagnosis (PGD), a method which indicates the presence of genetic mutations in embryos. Researchers who conducted this study say their gene-correcting method could be used in conjunction with PGD in the future to treat embryos. But Jennifer Doudna, one of the creators of CRISPR, says "It may be possible in the not-too-distant future to avoid embryo editing altogether by editing gametes [egg and sperm cells] prior to embryogenesis."
  • Difficult questions will arise at each stage of the research, Berg says. If an embryo is genetically modified, but there is a mistake, to discard it raises questions of abortion. Another ethical question is the idea of "changing progeny," and the implications of that for society, Michael Werner, executive director at the Alliance for Regenerative Medicine, told Axios. And the Oregon scientists only demonstrated that the genetic flaw was successfully corrected to a certain number of divisions. Berg asks, "How much evidence do you need before you can say this really works?"
  • We don't like the word "editing," says Shoukhrat Mitalipov, the study's lead researcher. They prefer "correcting": the study isolated one genetic flaw and fixed it. "It is nowhere near designing babies," Berg says. "[The researchers] weren't saying … 'we wanted a taller baby or a smarter baby' … that was nothing like this."

Go deeper

Ina Fried, author of Login
1 min ago - Technology

Google's parent shuts down effort to deliver Internet via balloons

Image: Loon

Alphabet is shutting down Loon, one of its "moonshots" which aimed to deliver Internet service via high-altitude balloons.

Why it matters: The effort was one of several approaches designed to get high-speed connectivity to some of the world's remote spots and also proved useful in the aftermath of disasters that shut down traditional infrastructure.

Dave Lawler, author of World
17 mins ago - World

What has and hasn't changed as Biden takes over U.S. foreign policy

Photo Illustration: Brendan Lynch/Axios. Photo: Chip Somodevilla/Getty Images

President Biden swiftly recommitted the U.S. to the Paris climate pact and the World Health Organization, but America's broader foreign policy is in a state of flux between the Trump and Biden eras.

Driving the news: One of the most striking moves from the Biden administration thus far was a show of continuity — concurring with the Trump administration's last-minute determination that China had committed "genocide" against Uyghur Muslims.

Updated 2 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Health: New coronavirus cases down, but more bad news ahead — Fighting COVID-19's effects on gender equality.
  2. Politics: Biden unveils "wartime" COVID strategyBiden's COVID-19 bubble.
  3. Vaccine: NYC postpones vaccine appointments following shipment delays — Private companies step in to fill vaccine logistics vacuum.
  4. World: Biden will order U.S. to rejoin World Health OrganizationBiden to bring U.S. into global COVAX initiative for equitable vaccine access.

You’ve caught up. Now what?

Sign up for Mike Allen’s daily Axios AM and PM newsletters to get smarter, faster on the news that matters.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!